Skip Navigation

Salud: Enfermedades crónicas

Noticias

  • Imprimir
  • Comentar

Schistosomiasis worms sequenced

Wu Chong

21 julio 2009 | EN | 中文

No more secrets: S.masoni larvae

CDC/Dr Sulzer

The genomes of two of the parasitic worms that cause schistosomiasis have been sequenced, paving the way for the development of new drugs for the debilitating disease.

Schistosomiasis afflicts hundreds of millions of people in tropical areas. The worms, called schistosomes, burrow through the skin and migrate to the organs. The body's immune response to the worm's eggs causes symptoms such as fever and aches.

The genome sequences of Schistosoma mansoni, the most widespread cause of schistosomiasis, and Schistosoma japonicum, which causes the disease in Asia, were published in Nature last week (16 July).

The genome sequences constitute "a crucial first step towards developing additional drugs and possibly vaccines that are urgently needed to deploy against schistosomiasis", says Najib El-Sayed, associate professor at the US-based University of Maryland and co-author of the S. mansoni study.

El-Sayed's team, consisting of European, Japanese and US scientists, drew a genetic map of S. mansoni, while another team led by Chinese scientists did the same for S. japonicum.

Both studies yielded important findings about the parasites' nerve systems, metabolism and relationships with the host, providing targets for potential new drugs or vaccines, says El-Sayed.

His team looked for targets for which drugs already exist. "The advantage of drug repositioning or repurposing is that candidate drugs would have already passed all the safety and toxicity tests in humans," he says.

S. mansoni and S. japonicum are two of the three principal species of the worm that infect humans. There is currently only one approved drug against the disease, praziquantel, leading to concerns that the worms might become resistant.

Joanne Webster, director of monitoring and evaluation at the Schistosome Control Initiative at Imperial College London in the United Kingdom, hopes that the genomes will lead to new drug targets.

"Knowing more about the genome of these schistosomes will also open up new avenues for related research, such as into the population genetic structure and transmission dynamics of these parasites," she adds.

Webster says she expects the genome of the third schistosome, S. haematobium, which causes urinary schistosomiasis across much of Sub-Saharan Africa, to be sequenced soon.

Link to Schistosoma masoni article in Nature

Link to Schistosoma japonicum article in Nature

REFERENCIAS

Nature 460, 352 (2009)

Nature 460, 345 (2009)

AGREGUE SU COMENTARIO

Esta es su red: comparta sus opiniones sobre cualquiera de nuestros artículos agregando sus comentarios.

Usted debe registrarse para enviar un comentario o para escribir a un autor que haya aceptado recibir comentarios. Por favor entrarsuscribirse.

Todos los comentarios están sujetos a revisión. Nos reservamos el derecho de editar los comentarios que contengan un lenguaje inapropiado o inadecuado. SciDev.Net mantiene los derechos de autor de todo el material que se publica en el portal. Por favor lea las condiciones de uso para más detalles.

Todo el material de SciDev.Net se puede reproducir gratuitamente siempre que se de crédito a la fuente y al autor. Para más detalles ver Creative commons.

Volver Noticias
Subir